NOT:FRA
«Նովարտիս»
127,88 €
0,00%
(0,00) 1D
30 սեպ, 13:38:39 GMT+2 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for NOT...
Mkt. cap
240,70 մլրդ
Avg. vol.
1,08 հզր
Volume
0,00
52-wk high
144,08 €
52-wk low
105,24 €
No. of employees
75 հզր
Mkt. cap
240,70 մլրդ
Avg. vol.
1,08 հզր
Volume
0,00
52-wk high
144,08 €
52-wk low
105,24 €
No. of employees
75 հզր
News stories
From web sources and news partners
AD HOC NEWS
·
1 ժամ առաջ
Novartis stock pre-market at EUR 125.99: plus 0.27 percent
AD HOC NEWS
·
11 ժամ առաջ
Novartis stock after-hours at EUR 125.66: minus 2.04 percent versus prior close
Yahoo Finance
·
1 օր առաջ
CAS announces collaboration with Novartis to advance AI-ready reaction informatics
BioSpace
·
2 օր առաջ
3 steps for taking on Novartis in radiopharma: Curium up first
Profile
Novartis AG is a Swiss multinational pharmaceutical corporation based in Basel, Switzerland. Novartis is one of the largest pharmaceutical companies in the world and was the eighth largest by revenue in 2024.
Novartis manufactures the drugs clozapine, diclofenac, carbamazepine, valsartan, imatinib mesylate, cyclosporine, letrozole, methylphenidate, terbinafine, deferasirox, and others.
Novartis was formed in 1996 by the merger of Ciba-Geigy and Sandoz. It was considered the largest corporate merger in history during that time. The pharmaceutical and agrochemical divisions of both companies formed Novartis as an independent entity. The name Novartis was based on the Latin terms, novae artes.
After the merger, other Ciba-Geigy and Sandoz businesses were sold, or, like Ciba Specialty Chemicals, spun off as independent companies. The Sandoz brand disappeared for three years, but was revived in 2003 when Novartis consolidated its generic drugs businesses into a single subsidiary and named it Sandoz. Wikipedia
About «Նովարտիս»
CEOVasant Narasimhan
Employees75,3 հզր
Founded07 մրտ, 1996 թ.
HeadquartersԲասել, Basel City, Շվեյցարիա
Sector-
Websitenovartis.com